Cardiac function in 6-year-old children born extremely preterm and associations to prolonged patent ductus arteriosus

Jonna Karlén1,2, Lilly-Ann Mohlkert3,4, Anna Gudmundsdottir5,6

  • 1Department of Clinical Science and Education, Stockholm South General Hospital (Södersjukhuset), Karolinska Institutet, Stockholm, Sweden. jonna.karlen@ki.se.

Scientific Reports
|January 8, 2026
PubMed

Insights

Extremely preterm born children show altered heart development. However, prolonged patent ductus arteriosus (PDA) shunting did not lead to significant long-term cardiac issues by age 6.5.

Area of Science:

  • Neonatal cardiology
  • Pediatric cardiac imaging
  • Fetal and neonatal development

Background:

  • Extremely preterm born (EPT) individuals often exhibit reduced cardiac dimensions and altered biventricular function compared to term-born controls.
  • A hemodynamically significant patent ductus arteriosus (hsPDA) increases neonatal cardiac load, but long-term impacts of prolonged shunting remain unclear.

Purpose of the Study:

  • To assess cardiac dimensions and function in EPT children at 6.5 years of age.
  • To investigate the long-term cardiac impact of prolonged neonatal hsPDA shunting.

Main Methods:

  • Follow-up study involving EPT children (n=57) and term-born controls (n=63).
  • Repeated neonatal echocardiograms to assess PDA shunt duration.
  • Echocardiography at 6.5 years for cardiac measurements and function analysis.
  • Subgroup analysis based on neonatal PDA shunt duration.

Main Results:

  • EPT children displayed significantly smaller heart chambers and a more globe-shaped left ventricle compared to controls.
  • Altered biventricular systolic function was observed in EPT children.
  • No major cardiac alterations were found in EPT children with hsPDA shunt duration >21 days compared to those with shorter durations.

Conclusions:

  • Early cardiac remodeling is supported in extremely preterm born individuals.
  • Prolonged neonatal hsPDA shunting does not appear to cause significant long-term cardiac alterations by age 6.5.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
435
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457